PUBLISHER: 360iResearch | PRODUCT CODE: 1613031
PUBLISHER: 360iResearch | PRODUCT CODE: 1613031
Cocaine Use Disorder Market by Therapeutic Approaches (Behavioral Therapies, Cognitive-Behavioral Therapy, Contingency Management), Medications (Anticonvulsants, Antidepressants, Antipsychotics), Treatment Setting - Global Forecast 2025-2030
The Cocaine Use Disorder Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 6.21%, to USD 2.01 billion by 2030.
Cocaine Use Disorder (CUD) is a significant public health issue characterized by the compulsive use of cocaine, leading to clinically significant impairment or distress. Its market scope primarily involves pharmaceutical companies, research institutions, healthcare providers, and rehabilitation centers developing treatments and therapies targeted at CUD. The necessity of addressing CUD is underscored by its high societal costs, ranging from healthcare expenses to lost productivity and legal implications. This calls for comprehensive applications, such as medication-assisted treatments, behavioral therapies, and innovative approaches involving genetic and neurobiological research. End-use primarily spans hospitals, rehabilitation facilities, and even telemedicine platforms aiming to expand outreach for affected individuals.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 1.32 billion |
| Estimated Year [2024] | USD 1.39 billion |
| Forecast Year [2030] | USD 2.01 billion |
| CAGR (%) | 6.21% |
Market growth factors include increasing awareness about substance use disorders, enhanced healthcare infrastructure, and ongoing research into novel treatment methodologies. The rising societal burden of CUD, combined with progressive healthcare policies, propels the demand for more effective intervention strategies. Opportunities in this market are highlighted by the integration of digital health technologies and AI-driven personalized treatment plans. Companies could invest in mobile applications for monitoring and encouraging patient adherence or AI tools for early detection and prevention strategies. However, limitations such as stringent regulatory frameworks, the social stigma surrounding addiction, and challenges in clinical trials due to complex behavioral health variables may impede market growth.
The market offers prime avenues for innovation, including the exploration of neuromodulation techniques and the development of non-addictive therapeutics that target specific brain pathways involved in cocaine addiction. Furthermore, cross-industry collaborations, especially with tech firms focusing on AI and machine learning, could bolster research and development initiatives. The nature of the market is one of cautious optimism, with considerable potential harnessed through sustained innovation and multi-disciplinary partnerships aimed at both treating and understanding the multifaceted aspects of cocaine addiction. Expanding initiatives to include global partnerships can also alleviate regional disparities and accelerate market maturity.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cocaine Use Disorder Market
The Cocaine Use Disorder Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Growing prevalence of cocaine use worldwide
- Increasing awareness and social acceptance of addiction issues, necessitating the treatments for cocaine use disorders
- Governmental and private funding for addiction treatment programs
- Market Restraints
- Limited availability of specialized healthcare providers and social stigmas associated with cocaine addiction
- Market Opportunities
- Innovative medicine approaches utilizing genetic and psychosocial markers to tailor personalized treatments
- Application of artificial intelligence and machine learning in predicting treatment outcomes and enhancements in patient engagement through digital platforms
- Market Challenges
- Regulatory hurdles and variability in treatment effectiveness across populations worldwide
Porter's Five Forces: A Strategic Tool for Navigating the Cocaine Use Disorder Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cocaine Use Disorder Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Cocaine Use Disorder Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cocaine Use Disorder Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Cocaine Use Disorder Market
A detailed market share analysis in the Cocaine Use Disorder Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cocaine Use Disorder Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cocaine Use Disorder Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Cocaine Use Disorder Market
A strategic analysis of the Cocaine Use Disorder Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Cocaine Use Disorder Market, highlighting leading vendors and their innovative profiles. These include Alkermes PLC, Alnylam Pharmaceuticals, Inc., Camurus AB, Indivior PLC, Johnson & Johnson Services, Inc., KemPharm, Inc., Novartis International AG, Orexo AB, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Revive Therapeutics Ltd., Sage Therapeutics, Inc., Shionogi & Co., Ltd., Teva Pharmaceuticals USA, Inc., and Viatris Inc..
Market Segmentation & Coverage
This research report categorizes the Cocaine Use Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Therapeutic Approaches, market is studied across Behavioral Therapies, Cognitive-Behavioral Therapy, Contingency Management, Medication-Assisted Treatment, and Motivational Enhancement.
- Based on Medications, market is studied across Anticonvulsants, Antidepressants, Antipsychotics, and Psychostimulants.
- Based on Treatment Setting, market is studied across Hospital-Based Treatment Programs, Inpatient Rehabilitation Centers, Outpatient Rehabilitation Centers, and Residential Rehabilitation Facilities.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing prevalence of cocaine use worldwide
- 5.1.1.2. Increasing awareness and social acceptance of addiction issues, necessitating the treatments for cocaine use disorders
- 5.1.1.3. Governmental and private funding for addiction treatment programs
- 5.1.2. Restraints
- 5.1.2.1. Limited availability of specialized healthcare providers and social stigmas associated with cocaine addiction
- 5.1.3. Opportunities
- 5.1.3.1. Innovative medicine approaches utilizing genetic and psychosocial markers to tailor personalized treatments
- 5.1.3.2. Application of artificial intelligence and machine learning in predicting treatment outcomes and enhancements in patient engagement through digital platforms
- 5.1.4. Challenges
- 5.1.4.1. Regulatory hurdles and variability in treatment effectiveness across populations worldwide
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Treatment Setting: Increasing preference for residential rehabilitation facilities
- 5.2.2. Medications: Need based preference for psychostimulants for treatment of cocaine use disorder
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Cocaine Use Disorder Market, by Therapeutic Approaches
- 6.1. Introduction
- 6.2. Behavioral Therapies
- 6.3. Cognitive-Behavioral Therapy
- 6.4. Contingency Management
- 6.5. Medication-Assisted Treatment
- 6.6. Motivational Enhancement
7. Cocaine Use Disorder Market, by Medications
- 7.1. Introduction
- 7.2. Anticonvulsants
- 7.3. Antidepressants
- 7.4. Antipsychotics
- 7.5. Psychostimulants
8. Cocaine Use Disorder Market, by Treatment Setting
- 8.1. Introduction
- 8.2. Hospital-Based Treatment Programs
- 8.3. Inpatient Rehabilitation Centers
- 8.4. Outpatient Rehabilitation Centers
- 8.5. Residential Rehabilitation Facilities
9. Americas Cocaine Use Disorder Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Cocaine Use Disorder Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Cocaine Use Disorder Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. Scientists Develop a Vaccine For Cocaine
- 12.3.2. FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Alkermes PLC
- 2. Alnylam Pharmaceuticals, Inc.
- 3. Camurus AB
- 4. Indivior PLC
- 5. Johnson & Johnson Services, Inc.
- 6. KemPharm, Inc.
- 7. Novartis International AG
- 8. Orexo AB
- 9. Otsuka Pharmaceutical Co., Ltd.
- 10. Pfizer Inc.
- 11. Revive Therapeutics Ltd.
- 12. Sage Therapeutics, Inc.
- 13. Shionogi & Co., Ltd.
- 14. Teva Pharmaceuticals USA, Inc.
- 15. Viatris Inc.
LIST OF FIGURES
- FIGURE 1. COCAINE USE DISORDER MARKET RESEARCH PROCESS
- FIGURE 2. COCAINE USE DISORDER MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. COCAINE USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. COCAINE USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. COCAINE USE DISORDER MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. COCAINE USE DISORDER MARKET DYNAMICS
- TABLE 7. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COGNITIVE-BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY CONTINGENCY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATION-ASSISTED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY HOSPITAL-BASED TREATMENT PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY INPATIENT REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY RESIDENTIAL REHABILITATION FACILITIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 23. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 24. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 25. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 26. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 27. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 28. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 29. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 30. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 31. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 32. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 33. CANADA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 34. CANADA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 35. CANADA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 36. MEXICO COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 37. MEXICO COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 38. MEXICO COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 39. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 40. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 41. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 42. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 43. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 44. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 45. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 46. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 47. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 48. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 49. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 50. CHINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 51. CHINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 52. CHINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 53. INDIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 54. INDIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 55. INDIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 56. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 57. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 58. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 59. JAPAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 60. JAPAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 61. JAPAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 62. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 63. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 64. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 65. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 66. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 67. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 68. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 69. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 70. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 71. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 72. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 73. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 74. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 75. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 76. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 77. THAILAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 78. THAILAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 79. THAILAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 80. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 81. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 82. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 83. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 84. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 85. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 86. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 87. DENMARK COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 88. DENMARK COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 89. DENMARK COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 90. EGYPT COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 91. EGYPT COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 92. EGYPT COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 93. FINLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 94. FINLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 95. FINLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 96. FRANCE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 97. FRANCE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 98. FRANCE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 99. GERMANY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 100. GERMANY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 101. GERMANY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 102. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 103. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 104. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 105. ITALY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 106. ITALY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 107. ITALY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 108. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 109. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 110. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 111. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 112. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 113. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 114. NORWAY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 115. NORWAY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 116. NORWAY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 117. POLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 118. POLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 119. POLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 120. QATAR COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 121. QATAR COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 122. QATAR COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 123. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 124. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 125. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 126. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 127. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 128. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 129. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 130. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 131. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 132. SPAIN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 133. SPAIN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 134. SPAIN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 135. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 136. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 137. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 138. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 139. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 140. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 141. TURKEY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 142. TURKEY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 143. TURKEY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 144. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 145. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 146. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 147. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
- TABLE 148. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
- TABLE 149. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
- TABLE 150. COCAINE USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 151. COCAINE USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023
